1 of 4
Self-Monitoring Blood Glucose Devices Market Overview:
Diabetes is a clinical condition where the glucose level in the blood increases due to inability of the pancreas to produce insulin. Glucose monitoring is one of the essential steps toward diabetes management. Monitoring of blood glucose helps patients decide the amount of food intake, dosage of insulin, as well as type of physical exercise required for the day. Self-monitoring blood glucose (SMBG) is modern diabetes management procedure, which involves the use of blood glucose meters to check glucose levels and provide an accurate measure of capillary glucose concentrations. SMBG technology uses test strips, lancets, and blood glucose meters to achieve better long-term glycemic control.
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Factors such as rise in prevalence of diabetes caused by rapid urbanization and sedentary lifestyle significantly drive the growth of the global self-monitoring blood glucose devices market. Moreover, technological advancements in the field of diabetes devices, rise in obese population, consumption of junk food, and surge in need for faster & safer diagnosis as well as treatment of diabetes further boosts the market growth. However, blood glucose monitoring devices provide the glucose level reading as a range and do not measure the exact level of glucose in blood. Moreover, high cost of blood glucose measuring devices hinders the market growth. Conversely, huge untapped market potential in the emerging countries, such as China and India, and rise in awareness about diabetes monitoring devices are expected to offer lucrative opportunities to the market players.
The global self-monitoring blood glucose devices market is segmented based on product, application, end user, and region. Depending on product, the market is divided into test strips, lancets, and blood glucose meters. By application, the self-monitoring blood glucose devices market is categorized into type 1 diabetes, type 2 diabetes, and gestational diabetes. Based on end user, the market is classified into hospitals home settings, and diagnostic centers. Based on region, the self-monitoring blood glucose devices market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for Self-Monitoring Blood Glucose Devices Market:
By Product
READ MORE Diabetes is a clinical condition where the glucose level in the blood increases due to inability of the pancreas to produce insulin. Glucose monitoring is one of the essential steps toward diabetes management. Monitoring of blood glucose helps patients decide the amount of food intake, dosage of insulin, as well as type of physical exercise required for the day. Self-monitoring blood glucose (SMBG) is modern diabetes management procedure, which involves the use of blood glucose meters to check glucose levels and provide an accurate measure of capillary glucose concentrations. SMBG technology uses test strips, lancets, and blood glucose meters to achieve better long-term glycemic control.
The global self-monitoring blood glucose devices market was valued at $7,768 million in 2017 and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025. Factors such as rise in prevalence of diabetes caused by rapid urbanization and sedentary lifestyle significantly drive the growth of the global self-monitoring blood glucose devices market. Moreover, technological advancements in the field of diabetes devices, rise in obese population, consumption of junk food, and surge in need for faster & safer diagnosis as well as treatment of diabetes further boosts the market growth. However, blood glucose monitoring devices provide the glucose level reading as a range and do not measure the exact level of glucose in blood. Moreover, high cost of blood glucose measuring devices hinders the market growth. Conversely, huge untapped market potential in the emerging countries, such as China and India, and rise in awareness about diabetes monitoring devices are expected to offer lucrative opportunities to the market players.
The global self-monitoring blood glucose devices market is segmented based on product, application, end user, and region. Depending on product, the market is divided into test strips, lancets, and blood glucose meters. By application, the self-monitoring blood glucose devices market is categorized into type 1 diabetes, type 2 diabetes, and gestational diabetes. Based on end user, the market is classified into hospitals home settings, and diagnostic centers. Based on region, the self-monitoring blood glucose devices market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for Self-Monitoring Blood Glucose Devices Market:
- The study provides an in-depth analysis of the global self-monitoring blood glucose devices market along with the current trends and future estimations from 2018 to 2025 to elucidate the imminent investment pockets.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on the global & regional scale are provided.
- Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
By Product
- Test Strips
- Lancets
- Blood Glucose Meters
- By Application
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
- Hospitals
- Home Settings
- Diagnostic Centers
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Abbott Laboratories
- Becton, Dickinson and Company
- B. Braun Melsungen AG
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- Medtronic plc
- PHC Holdings Corporation
- Sanofi
- Terumo Corporation
- Trividia Health, Inc.
- ARKRAY USA
- Nova Biomedical
- Bionime Corporation
- Sinocare, Inc.
- All Medicus Co., Ltd.
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of key players profiled in the report
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key Findings of the Study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Market Share Analysis, 2017 (%)
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Increase in the incidence rate of diabetes
3.4.1.2. Rise in geriatric population
3.4.1.3. Technological advancements in diabetes monitoring devices
3.4.1.4. Rise in risk factors that lead to diabetes
3.4.2. Restraints
3.4.2.1. Inaccurate results
3.4.3. Opportunity
3.4.3.1. Increase in awareness for diabetes monitoring devices
3.4.3.2. Untapped market opportunities in the developing regions
3.4.4. Impact analyses
CHAPTER 4: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast, by product
4.2. Test Strips
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Lancets
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Blood Glucose Meters
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast, by revenue
5.2. Type 1 Diabetes
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Type 2 diabetes
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Gestational Diabetes
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
CHAPTER 6: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Home Settings
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Diagnostic Centers
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. market size and forecast, by product
7.2.2.1.2. U.S. market size and forecast, by application
7.2.2.1.3. U.S. market size and forecast, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada market size and forecast, by product
7.2.2.2.2. Canada market size and forecast, by application
7.2.2.2.3. Canada market size and forecast, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico market size and forecast, by product
7.2.2.3.2. Mexico market size and forecast, by application
7.2.2.3.3. Mexico market size and forecast, by end user
7.2.3. North America market size and forecast, by product
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe self-monitoring blood glucose devices market, by country
7.3.2.1. Germany
7.3.2.1.1. Germany market size and forecast, by product
7.3.2.1.2. Germany market size and forecast, by application
7.3.2.1.3. Germany market size and forecast, by end user
7.3.2.2. France
7.3.2.2.1. France market size and forecast, by product
7.3.2.2.2. France market size and forecast, by application
7.3.2.2.3. France market size and forecast, by end user
7.3.2.3. UK
7.3.2.3.1. UK market size and forecast, by product
7.3.2.3.2. UK market size and forecast, by application
7.3.2.3.3. UK market size and forecast, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy market size and forecast, by product
7.3.2.4.2. Italy market size and forecast, by application
7.3.2.4.3. Italy market size and forecast, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain market size and forecast, by product
7.3.2.5.2. Spain market size and forecast, by application
7.3.2.5.3. Spain market size and forecast, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe market size and forecast, by product
7.3.2.6.2. Rest of Europe market size and forecast, by application
7.3.2.6.3. Rest of Europe market size and forecast, by end user
7.3.3. Europe market size and forecast, by product
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan market size and forecast, by product
7.4.2.1.2. Japan market size and forecast, by application
7.4.2.1.3. Japan market size and forecast, by end user
7.4.2.2. China
7.4.2.2.1. China market size and forecast, by product
7.4.2.2.2. China market size and forecast, by application
7.4.2.2.3. China market size and forecast, by end user
7.4.2.3. India
7.4.2.3.1. India market size and forecast, by product
7.4.2.3.2. India market size and forecast, by application
7.4.2.3.3. India market size and forecast, by end user
7.4.2.4. Australia
7.4.2.4.1. Australia market size and forecast, by product
7.4.2.4.2. Australia market size and forecast, by application
7.4.2.4.3. Australia market size and forecast, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea market size and forecast, by product
7.4.2.5.2. South Korea market size and forecast, by application
7.4.2.5.3. South Korea market size and forecast, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product
7.4.2.6.2. Rest of Asia-Pacific market size and forecast, by application
7.4.2.6.3. Rest of Asia-Pacific market size and forecast, by end user
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil market size and forecast, by product
7.5.2.1.2. Brazil market size and forecast, by application
7.5.2.1.3. Brazil market size and forecast, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia market size and forecast, by product
7.5.2.2.2. Saudi Arabia market size and forecast, by application
7.5.2.2.3. Saudi Arabia market size and forecast, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Arica market size and forecast, by product
7.5.2.3.2. South Arica market size and forecast, by application
7.5.2.3.3. South Arica market size and forecast, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA market size and forecast, by product
7.5.2.4.2. Rest of LAMEA market size and forecast, by application
7.5.2.4.3. Rest of LAMEA market size and forecast, by end user
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. Abbott Laboratories
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product Portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. Becton, Dickinson and Company
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product Portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. B. Braun Melsungen AG
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product Portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. F. Hoffmann-La Roche Ltd.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. Johnson & Johnson
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product Portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Medtronic plc
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product Portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. PHC Holdings Corporation
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Key strategic moves and developments
8.8. Sanofi
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product Portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. Terumo Corporation
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product Portfolio
8.9.5. Business performance
8.10. Trividia Health, Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of key players profiled in the report
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key Findings of the Study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Market Share Analysis, 2017 (%)
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Increase in the incidence rate of diabetes
3.4.1.2. Rise in geriatric population
3.4.1.3. Technological advancements in diabetes monitoring devices
3.4.1.4. Rise in risk factors that lead to diabetes
3.4.2. Restraints
3.4.2.1. Inaccurate results
3.4.3. Opportunity
3.4.3.1. Increase in awareness for diabetes monitoring devices
3.4.3.2. Untapped market opportunities in the developing regions
3.4.4. Impact analyses
CHAPTER 4: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast, by product
4.2. Test Strips
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Lancets
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Blood Glucose Meters
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast, by revenue
5.2. Type 1 Diabetes
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Type 2 diabetes
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Gestational Diabetes
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
CHAPTER 6: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Home Settings
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Diagnostic Centers
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7: SELF-MONITORING BLOOD GLUCOSE DEVICES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. market size and forecast, by product
7.2.2.1.2. U.S. market size and forecast, by application
7.2.2.1.3. U.S. market size and forecast, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada market size and forecast, by product
7.2.2.2.2. Canada market size and forecast, by application
7.2.2.2.3. Canada market size and forecast, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico market size and forecast, by product
7.2.2.3.2. Mexico market size and forecast, by application
7.2.2.3.3. Mexico market size and forecast, by end user
7.2.3. North America market size and forecast, by product
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe self-monitoring blood glucose devices market, by country
7.3.2.1. Germany
7.3.2.1.1. Germany market size and forecast, by product
7.3.2.1.2. Germany market size and forecast, by application
7.3.2.1.3. Germany market size and forecast, by end user
7.3.2.2. France
7.3.2.2.1. France market size and forecast, by product
7.3.2.2.2. France market size and forecast, by application
7.3.2.2.3. France market size and forecast, by end user
7.3.2.3. UK
7.3.2.3.1. UK market size and forecast, by product
7.3.2.3.2. UK market size and forecast, by application
7.3.2.3.3. UK market size and forecast, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy market size and forecast, by product
7.3.2.4.2. Italy market size and forecast, by application
7.3.2.4.3. Italy market size and forecast, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain market size and forecast, by product
7.3.2.5.2. Spain market size and forecast, by application
7.3.2.5.3. Spain market size and forecast, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe market size and forecast, by product
7.3.2.6.2. Rest of Europe market size and forecast, by application
7.3.2.6.3. Rest of Europe market size and forecast, by end user
7.3.3. Europe market size and forecast, by product
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan market size and forecast, by product
7.4.2.1.2. Japan market size and forecast, by application
7.4.2.1.3. Japan market size and forecast, by end user
7.4.2.2. China
7.4.2.2.1. China market size and forecast, by product
7.4.2.2.2. China market size and forecast, by application
7.4.2.2.3. China market size and forecast, by end user
7.4.2.3. India
7.4.2.3.1. India market size and forecast, by product
7.4.2.3.2. India market size and forecast, by application
7.4.2.3.3. India market size and forecast, by end user
7.4.2.4. Australia
7.4.2.4.1. Australia market size and forecast, by product
7.4.2.4.2. Australia market size and forecast, by application
7.4.2.4.3. Australia market size and forecast, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea market size and forecast, by product
7.4.2.5.2. South Korea market size and forecast, by application
7.4.2.5.3. South Korea market size and forecast, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product
7.4.2.6.2. Rest of Asia-Pacific market size and forecast, by application
7.4.2.6.3. Rest of Asia-Pacific market size and forecast, by end user
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil market size and forecast, by product
7.5.2.1.2. Brazil market size and forecast, by application
7.5.2.1.3. Brazil market size and forecast, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia market size and forecast, by product
7.5.2.2.2. Saudi Arabia market size and forecast, by application
7.5.2.2.3. Saudi Arabia market size and forecast, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Arica market size and forecast, by product
7.5.2.3.2. South Arica market size and forecast, by application
7.5.2.3.3. South Arica market size and forecast, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA market size and forecast, by product
7.5.2.4.2. Rest of LAMEA market size and forecast, by application
7.5.2.4.3. Rest of LAMEA market size and forecast, by end user
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. Abbott Laboratories
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product Portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. Becton, Dickinson and Company
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product Portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. B. Braun Melsungen AG
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product Portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. F. Hoffmann-La Roche Ltd.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. Johnson & Johnson
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product Portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Medtronic plc
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product Portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. PHC Holdings Corporation
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Key strategic moves and developments
8.8. Sanofi
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product Portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. Terumo Corporation
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product Portfolio
8.9.5. Business performance
8.10. Trividia Health, Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
Note: Product cover images may vary from those shown
3 of 4
LOADING...
4 of 4
According to a new report titled, Self-Monitoring Blood Glucose Devices Market, by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018-2025, the market was valued at $7,768 million in 2017, and is projected to reach $10,828 million by 2025 at a CAGR of 4.2% from 2018 to 2025.
Diabetes is a clinical condition where the glucose level in blood increases due to inefficiency of pancreas to produce insulin. Diabetes management is used to control the blood sugar levels, which can be monitored by using blood glucose meters. Self-monitoring blood glucose devices are used to track and monitor blood glucose levels in diabetic patients.
The self-monitoring blood glucose devices market is anticipated to exhibit significant growth in the near future, owing to factors such as rise in prevalence of diabetes, surge in obese population who are prone to diabetes, technological advancements in diabetes devices, and surge in need for faster & safer diagnosis as well as treatment of diabetes. However, blood glucose monitoring devices do not measure the exact level of glucose in blood, whereas provide the readings in the form of a particular range. In addition, adverse effects associated with some of the diabetes care devices hinder the market growth. Rise in awareness about diabetes monitoring devices and untapped market opportunities in the developing regions are expected to provide numerous opportunities for the market growth.
By product, the test strips segment accounted for the maximum share of the global self-monitoring blood glucose devices market in 2017 and is projected to exhibit prominent growth rate, owing to increase in demand for test strips in various diabetes monitoring devices.
In 2017, the type 2 diabetes application segment occupied almost three-fourths share of the market, and is anticipated to maintain its dominant position through 2025, due to rise in prevalence of type 2 diabetes across the world.
In 2017, based on end user, the hospitals segment occupied more than two-fifth share of the market, highest amongst all other end users. Whereas, the home settings segment is anticipated to grow at the fastest rate during the forecast period.
Key findings of the Self-Monitoring Blood Glucose Devices Market:
Blood glucose meters accounted for more than one-eighth of the share of the self-monitoring blood glucose devices market in 2017.
The type 1 diabetes segment is anticipated to grow with the moderate CAGR throughout the forecast period.
Europe accounted for more than one-fourth of the global self-monitoring blood glucose devices market in 2017.
The LAMEA region is anticipated to grow at the high rate in the self-monitoring blood glucose devices market during the study period.
North America accounted for more than two-fifths share of the global market in 2017 and is expected to remain dominant throughout the forecast period. This is attributed to the increase in incidence of diabetes, growth in geriatric population, and adoption of sedentary lifestyle of people that leads to diabetes. In addition, high adoption rate of technologically advanced devices and presence of sophisticated healthcare infrastructure are expected to offer new growth opportunities to the market players in future.
Diabetes is a clinical condition where the glucose level in blood increases due to inefficiency of pancreas to produce insulin. Diabetes management is used to control the blood sugar levels, which can be monitored by using blood glucose meters. Self-monitoring blood glucose devices are used to track and monitor blood glucose levels in diabetic patients.
The self-monitoring blood glucose devices market is anticipated to exhibit significant growth in the near future, owing to factors such as rise in prevalence of diabetes, surge in obese population who are prone to diabetes, technological advancements in diabetes devices, and surge in need for faster & safer diagnosis as well as treatment of diabetes. However, blood glucose monitoring devices do not measure the exact level of glucose in blood, whereas provide the readings in the form of a particular range. In addition, adverse effects associated with some of the diabetes care devices hinder the market growth. Rise in awareness about diabetes monitoring devices and untapped market opportunities in the developing regions are expected to provide numerous opportunities for the market growth.
By product, the test strips segment accounted for the maximum share of the global self-monitoring blood glucose devices market in 2017 and is projected to exhibit prominent growth rate, owing to increase in demand for test strips in various diabetes monitoring devices.
In 2017, the type 2 diabetes application segment occupied almost three-fourths share of the market, and is anticipated to maintain its dominant position through 2025, due to rise in prevalence of type 2 diabetes across the world.
In 2017, based on end user, the hospitals segment occupied more than two-fifth share of the market, highest amongst all other end users. Whereas, the home settings segment is anticipated to grow at the fastest rate during the forecast period.
Key findings of the Self-Monitoring Blood Glucose Devices Market:
Blood glucose meters accounted for more than one-eighth of the share of the self-monitoring blood glucose devices market in 2017.
The type 1 diabetes segment is anticipated to grow with the moderate CAGR throughout the forecast period.
Europe accounted for more than one-fourth of the global self-monitoring blood glucose devices market in 2017.
The LAMEA region is anticipated to grow at the high rate in the self-monitoring blood glucose devices market during the study period.
North America accounted for more than two-fifths share of the global market in 2017 and is expected to remain dominant throughout the forecast period. This is attributed to the increase in incidence of diabetes, growth in geriatric population, and adoption of sedentary lifestyle of people that leads to diabetes. In addition, high adoption rate of technologically advanced devices and presence of sophisticated healthcare infrastructure are expected to offer new growth opportunities to the market players in future.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
